Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.36 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.36 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1776214 | 1.00 | NT5E (0.40) | NT5ESLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL1776211 | 1.00 | NT5E (0.40) | NT5ESLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL2911947 | 0.87 | NT5E (0.39) | NT5ESLC6A2SLC6A3KMT2ATDP1 | |
| SCHEMBL1777369 | 0.81 | MAPT (0.39) | NT5ELGALS3RNASE1 | |
| SCHEMBL1777367 | 0.81 | MAPT (0.39) | NT5ELGALS3RNASE1 | |
| SCHEMBL6306596 | 0.81 | KMT2A (0.46) | SLC6A2SLC6A3KMT2ATDP1PSEN1 | |
| SCHEMBL1775183 | 0.80 | BCHE (0.53) | NT5ELGALS3BCHEPTPN2PTPN1 | |
| SCHEMBL11374955 | 0.78 | LGALS9 (0.40) | LGALS9LGALS1LGALS3LGALS7; LGALS7BRNASE1 | |
| SCHEMBL11374956 | 0.78 | LGALS9 (0.40) | LGALS9LGALS1LGALS3LGALS7; LGALS7BRNASE1 | |
| SCHEMBL10429257 | 0.78 | TSHR (0.51) | KMT2APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943584-B2 | Medicinal composition containing diabetes remedy | SANKYO COMPANY, LIMITED (JP) | 2011-05-17 | — | — | US | disclosed |
| CN-101367851-A | Oligosaccharide derivative | SANKYO CO (JP) | 2009-02-18 | — | — | CN | disclosed |
| US-20080039367-A1 | Medicinal Composition Containing Diabeted Remedy | SANKYO COMPANY, LIMITED (JP) | 2008-02-14 | — | — | US | disclosed |
| CN-100360548-C | Oligosaccharide Derivatives | SANKYO CO (JP) | 2008-01-09 | — | — | CN | disclosed |
| EP-1792620-A1 | MEDICINAL COMPOSITION CONTAINING DIABETES REMEDY | Sankyo Company, Limited (JP) | 2007-06-06 | — | — | EP | disclosed |
| CN-1768073-A | Oligosaccharide Derivatives | SANKYO CO (JP) | 2006-05-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039367-A1 | Medicinal Composition Containing Diabeted Remedy | DPP4, IAPP, AMY2A | NT5E 1662/4885SLC6A2 2459/4885SLC6A3 1329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.